Literature DB >> 24038458

Inverse probability weighting for covariate adjustment in randomized studies.

Changyu Shen1, Xiaochun Li, Lingling Li.   

Abstract

Covariate adjustment in randomized clinical trials has the potential benefit of precision gain. It also has the potential pitfall of reduced objectivity as it opens the possibility of selecting a 'favorable' model that yields strong treatment benefit estimate. Although there is a large volume of statistical literature targeting on the first aspect, realistic solutions to enforce objective inference and improve precision are rare. As a typical randomized trial needs to accommodate many implementation issues beyond statistical considerations, maintaining the objectivity is at least as important as precision gain if not more, particularly from the perspective of the regulatory agencies. In this article, we propose a two-stage estimation procedure based on inverse probability weighting to achieve better precision without compromising objectivity. The procedure is designed in a way such that the covariate adjustment is performed before seeing the outcome, effectively reducing the possibility of selecting a 'favorable' model that yields a strong intervention effect. Both theoretical and numerical properties of the estimation procedure are presented. Application of the proposed method to a real data example is presented.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  clinical trials; covariate adjustment; efficiency; inverse probability weighting; objectivity

Mesh:

Substances:

Year:  2013        PMID: 24038458      PMCID: PMC3899802          DOI: 10.1002/sim.5969

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  18 in total

1.  A note on non-parametric ANCOVA for covariate adjustment in randomized clinical trials.

Authors:  Emmanuel Lesaffre; Stephen Senn
Journal:  Stat Med       Date:  2003-12-15       Impact factor: 2.373

2.  Repeated measures in clinical trials: analysis using mean summary statistics and its implications for design.

Authors:  L Frison; S J Pocock
Journal:  Stat Med       Date:  1992-09-30       Impact factor: 2.373

3.  On the covariate-adjusted estimation for an overall treatment difference with data from a randomized comparative clinical trial.

Authors:  Lu Tian; Tianxi Cai; Lihui Zhao; Lee-Jen Wei
Journal:  Biostatistics       Date:  2012-01-30       Impact factor: 5.899

4.  Empirical efficiency maximization: improved locally efficient covariate adjustment in randomized experiments and survival analysis.

Authors:  Daniel B Rubin; Mark J van der Laan
Journal:  Int J Biostat       Date:  2008       Impact factor: 0.968

5.  A note on overadjustment in inverse probability weighted estimation.

Authors:  Andrea Rotnitzky; Lingling Li; Xiaochun Li
Journal:  Biometrika       Date:  2010-07-31       Impact factor: 2.445

6.  On weighting approaches for missing data.

Authors:  Lingling Li; Changyu Shen; Xiaochun Li; James M Robins
Journal:  Stat Methods Med Res       Date:  2011-06-24       Impact factor: 3.021

7.  Prognosis in primary biliary cirrhosis: model for decision making.

Authors:  E R Dickson; P M Grambsch; T R Fleming; L D Fisher; A Langworthy
Journal:  Hepatology       Date:  1989-07       Impact factor: 17.425

8.  How to select covariates to include in the analysis of a clinical trial.

Authors:  G M Raab; S Day; J Sales
Journal:  Control Clin Trials       Date:  2000-08

9.  Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems.

Authors:  Stuart J Pocock; Susan E Assmann; Laura E Enos; Linda E Kasten
Journal:  Stat Med       Date:  2002-10-15       Impact factor: 2.373

10.  Covariate adjustment for two-sample treatment comparisons in randomized clinical trials: a principled yet flexible approach.

Authors:  Anastasios A Tsiatis; Marie Davidian; Min Zhang; Xiaomin Lu
Journal:  Stat Med       Date:  2008-10-15       Impact factor: 2.373

View more
  7 in total

1.  Adaptive pre-specification in randomized trials with and without pair-matching.

Authors:  Laura B Balzer; Mark J van der Laan; Maya L Petersen
Journal:  Stat Med       Date:  2016-07-19       Impact factor: 2.373

2.  Leveraging prognostic baseline variables to gain precision in randomized trials.

Authors:  Elizabeth Colantuoni; Michael Rosenblum
Journal:  Stat Med       Date:  2015-04-14       Impact factor: 2.373

3.  Targeted estimation and inference for the sample average treatment effect in trials with and without pair-matching.

Authors:  Laura B Balzer; Maya L Petersen; Mark J van der Laan
Journal:  Stat Med       Date:  2016-04-18       Impact factor: 2.373

4.  A new approach to hierarchical data analysis: Targeted maximum likelihood estimation for the causal effect of a cluster-level exposure.

Authors:  Laura B Balzer; Wenjing Zheng; Mark J van der Laan; Maya L Petersen
Journal:  Stat Methods Med Res       Date:  2018-06-19       Impact factor: 3.021

5.  Generalizing trial evidence to target populations in non-nested designs: Applications to AIDS clinical trials.

Authors:  Fan Li; Ashley L Buchanan; Stephen R Cole
Journal:  J R Stat Soc Ser C Appl Stat       Date:  2022-03-17       Impact factor: 1.680

6.  Marijuana use and suicidal behaviours among school-going adolescents in Africa: assessments of prevalence and risk factors from the Global School-Based Student Health Survey.

Authors:  John Tetteh; George Ekem-Ferguson; Emmanuel Nii-Boye Quarshie; Swithin Mustapha Swaray; Martin Amogre Ayanore; Nana Ayegua Hagan Seneadza; Kwaku Oppong Asante; Alfred Edwin Yawson
Journal:  Gen Psychiatr       Date:  2021-08-26

Review 7.  No wisdom in the crowd: genome annotation in the era of big data - current status and future prospects.

Authors:  Antoine Danchin; Christos Ouzounis; Taku Tokuyasu; Jean-Daniel Zucker
Journal:  Microb Biotechnol       Date:  2018-05-28       Impact factor: 5.813

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.